Skip to main content
PulseWire News
PoliticsManhattan, New York

Rod Nordland, Veteran War Correspondent, Passes Away at 75

Rod Nordland, a profound war reporter transformed by personal strife, dies of glioblastoma.

By Alex TraubSource: nytimes.com1 min read
Rod Nordland, Veteran War Correspondent, Passes Away at 75
Image via nytimes.com

In brief

Rod Nordland’s impactful career spanned over four decades, chronicling global conflicts before turning the lens on his journey through terminal illness.

Rod Nordland, a distinguished war reporter known for his extensive coverage of international conflicts, passed away on Wednesday at his home in Manhattan. He was 75 years old. His wife, Leila Segal, reported that the cause of death was glioblastoma, a severe form of brain cancer. Having been a prominent voice at The New York Times since 2009, Mr. Nordland dedicated most of his professional life to documenting wars across the globe. In 2019, following his cancer diagnosis, he penned a reflective article for The Times, prompting a personal exploration that ultimately evolved into his memoir, “Waiting for the Monsoon,” released the previous year. Nordland’s journalism style was shaped by the challenging circumstances of his childhood, leading him to focus on the stories of marginalized individuals affected by war. He often remarked on how the profession had shifted over the years, noting how it had become less accessible to those outside elite educational backgrounds. His journey in journalism began in the early 1970s, a time when urban dailies were robust enough to fund overseas reporting. He initially reported for The Philadelphia Inquirer, which sent him to Southeast Asia in 1979. Nordland's passion for reporting kept him abroad for nearly four decades, until his health necessitated a return to the United States. In this age of ever-changing journalism, Rod Nordland will be remembered for his tenacity and dedication, both to the stories of war and his own battle against cancer, leaving a notable legacy in the field.

Topics

More on this story